Lilly announced on Thursday, Dec. 5 a $3 billion expansion of its Kenosha County manufacturing facility. Lilly expects to add 750 highly skilled jobs to the current 100-plus workforce at this location ...

I n Southeastern Wisconsin, Eli Lilly and Company will invest $3 billion to expand a Kenosha County manufacturing facility it acquired from Nexus Pharmaceuticals Inc. earlier this year. Lilly expects ...

Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain INDIANAPOLIS, Nov. 3, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE ...

A site near Lake Houston Parkway and Common Dock Drive is being eyed as a potential Eli Lilly manufacturing campus — planning docs show nearly $6 billion in construction costs and roughly 604 ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...

Eli Lilly’s R&D has yielded innovations such as the metabolic disorder drugs Mounjaro and Zepbound, both discovered in the company’s labs. Lilly is now committing $4.5 billion for in-house innovations ...

INDIANAPOLIS (WISH) — Eli Lilly and Company revealed plans for over $50 billion in investments to their domestic pharmaceutical manufacturing capabilities. Wednesday, the company announced the ...

The investment will benefit millions of patients worldwide, boosting the production of the company's medicines, including those for diabetes and obesity The company plans to start construction on the ...

Lilly’s €2.6 billion production facility in the Netherlands will create 500 manufacturing jobs despite being an 'A-Z' AI ...

Eli Lilly and Company plans to more than double its investment at the LEAP Research and Innovation District in Lebanon, Indiana. The added investment will enhance the company’s capacity to manufacture ...

Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production capacity for its keenly watched experimental weight-loss pill, orforglipron, ...